Market Overview

Alnylam, Tekmira Resolve All Litigation; Alnylam to Make $65M One-Time Payment

Related ALNY
EPO Upholds Alnylam's McSwiggen Patent - Analyst Blog
UPDATE: Alnylam Receives Positive Opinion for Orphan Drug Designation in EU for ALN-TTRsc
Related TKMR
How Did You File and Do You Owe? - Real Time Insight
Race for Vaccines, Treatments as West Africa Ebola Death Toll Tops 100

Alnylam (NASDAQ: ALNY) and Tekmira Pharma (NASDAQ: TKMR) announced a settlement agreement that resolves all litigation between the companies, and has signed a new licensing agreement that restructures the relationship and provides clarity on all intellectual property and licensing issues between the companies. As a result of the restructuring and new agreements, Tekmira will receive $65 million within 10 days and is eligible to receive $10 million in near-term milestone payments expected to be received in 2013.

Posted-In: News Legal

 

Most Popular

Related Articles (ALNY + TKMR)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free